Cargando…
Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression
Computational techniques, and in particular molecular dynamics (MD) simulations, have been successfully used as a complementary technique to predict and analyse the structural behaviour of nucleic acids, including peptide nucleic acid- (PNA-) RNA hybrids. This study shows that a 7-base long PNA comp...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009323/ https://www.ncbi.nlm.nih.gov/pubmed/24829907 http://dx.doi.org/10.1155/2014/610718 |
_version_ | 1782479751351369728 |
---|---|
author | Amato, Felice Tomaiuolo, Rossella Nici, Fabrizia Borbone, Nicola Elce, Ausilia Catalanotti, Bruno D'Errico, Stefano Morgillo, Carmine Marco De Rosa, Giuseppe Mayol, Laura Piccialli, Gennaro Oliviero, Giorgia Castaldo, Giuseppe |
author_facet | Amato, Felice Tomaiuolo, Rossella Nici, Fabrizia Borbone, Nicola Elce, Ausilia Catalanotti, Bruno D'Errico, Stefano Morgillo, Carmine Marco De Rosa, Giuseppe Mayol, Laura Piccialli, Gennaro Oliviero, Giorgia Castaldo, Giuseppe |
author_sort | Amato, Felice |
collection | PubMed |
description | Computational techniques, and in particular molecular dynamics (MD) simulations, have been successfully used as a complementary technique to predict and analyse the structural behaviour of nucleic acids, including peptide nucleic acid- (PNA-) RNA hybrids. This study shows that a 7-base long PNA complementary to the seed region of miR-509-3p, one of the miRNAs involved in the posttranscriptional regulation of the CFTR disease-gene of Cystic Fibrosis, and bearing suitable functionalization at its N- and C-ends aimed at improving its resistance to nucleases and cellular uptake, is able to revert the expression of the luciferase gene containing the 3′UTR of the gene in A549 human lung cancer cells, in agreement with the MD results that pointed at the formation of a stable RNA/PNA heteroduplex notwithstanding the short sequence of the latter. The here reported results widen the interest towards the use of small PNAs as effective anti-miRNA agents. |
format | Online Article Text |
id | pubmed-4009323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-40093232014-05-14 Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression Amato, Felice Tomaiuolo, Rossella Nici, Fabrizia Borbone, Nicola Elce, Ausilia Catalanotti, Bruno D'Errico, Stefano Morgillo, Carmine Marco De Rosa, Giuseppe Mayol, Laura Piccialli, Gennaro Oliviero, Giorgia Castaldo, Giuseppe Biomed Res Int Research Article Computational techniques, and in particular molecular dynamics (MD) simulations, have been successfully used as a complementary technique to predict and analyse the structural behaviour of nucleic acids, including peptide nucleic acid- (PNA-) RNA hybrids. This study shows that a 7-base long PNA complementary to the seed region of miR-509-3p, one of the miRNAs involved in the posttranscriptional regulation of the CFTR disease-gene of Cystic Fibrosis, and bearing suitable functionalization at its N- and C-ends aimed at improving its resistance to nucleases and cellular uptake, is able to revert the expression of the luciferase gene containing the 3′UTR of the gene in A549 human lung cancer cells, in agreement with the MD results that pointed at the formation of a stable RNA/PNA heteroduplex notwithstanding the short sequence of the latter. The here reported results widen the interest towards the use of small PNAs as effective anti-miRNA agents. Hindawi Publishing Corporation 2014 2014-04-15 /pmc/articles/PMC4009323/ /pubmed/24829907 http://dx.doi.org/10.1155/2014/610718 Text en Copyright © 2014 Felice Amato et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Amato, Felice Tomaiuolo, Rossella Nici, Fabrizia Borbone, Nicola Elce, Ausilia Catalanotti, Bruno D'Errico, Stefano Morgillo, Carmine Marco De Rosa, Giuseppe Mayol, Laura Piccialli, Gennaro Oliviero, Giorgia Castaldo, Giuseppe Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression |
title | Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression |
title_full | Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression |
title_fullStr | Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression |
title_full_unstemmed | Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression |
title_short | Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression |
title_sort | exploitation of a very small peptide nucleic acid as a new inhibitor of mir-509-3p involved in the regulation of cystic fibrosis disease-gene expression |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009323/ https://www.ncbi.nlm.nih.gov/pubmed/24829907 http://dx.doi.org/10.1155/2014/610718 |
work_keys_str_mv | AT amatofelice exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression AT tomaiuolorossella exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression AT nicifabrizia exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression AT borbonenicola exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression AT elceausilia exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression AT catalanottibruno exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression AT derricostefano exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression AT morgillocarminemarco exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression AT derosagiuseppe exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression AT mayollaura exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression AT piccialligennaro exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression AT olivierogiorgia exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression AT castaldogiuseppe exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression |